Factors influencing the long-term success of periurethral collagen therapy in the office

Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):346-51. doi: 10.1007/s00192-005-0011-8. Epub 2005 Oct 14.

Abstract

Introduction: Glutaraldehyde crosslinked bovine collagen has been used for periurethral bulking for the treatment of urodynamic stress incontinence since 1989 with variable success. A retrospective study was undertaken to evaluate the factors involved in the long-term success of glutaraldehyde crosslinked bovine collagen used for periurethral bulking in the office.

Methods: Patients were followed objectively with stress testing after receiving periurethral collagen injection in the office under local anesthesia. Repeat injections were done as necessary during their follow-up appointments. The "success" group was defined as those women who demonstrated negative stress tests for over 1 year following their first injection.

Results: Nineteen of 184 women (10.3%) demonstrated negative stress tests for over 1 year following only one initial injection of glutaraldehyde crosslinked collagen. Their success lasted a mean of 829 days up to the time of follow-up.

Conclusion: Prior anti-incontinence surgery was the one factor analyzed that showed a trend toward this long lasting success. No other factors were predictive of negative stress tests for over 1 year. Prior anti-incontinence surgery seems to represent a factor involved in the long-term success of periurethral bulking in the office with glutaraldehyde crosslinked bovine collagen for the treatment of urodynamic stress incontinence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Collagen / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Injections / methods*
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Urethra*
  • Urinary Incontinence, Stress / therapy*

Substances

  • glutaraldehyde-cross-linked collagen
  • Collagen